REPORT OF TASK-FORCE ON CLINICAL USE OF FACTOR-IX CONCENTRATES

被引：0

|

作者：

MENACHE, D

机构：

[1] HOP BEAUJON,SERV CENT IMMUNOL & HEMATOL,F-92 CLICHY,FRANCE

[2] CTR HOP UNIV XAVIER BICHAT,PARIS,FRANCE

来源：

THROMBOSIS AND HAEMOSTASIS | 1976年 / 35卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：748 / 750

页数：3

相关论文

共 50 条

[21] THROMBOGENICITY ASSOCIATED WITH FACTOR-IX COMPLEX CONCENTRATES
LUSHER, JM
SEMINARS IN HEMATOLOGY, 1991, 28 (03) : 3 - 5
[22] TASK-FORCE REPORT
HAGGERTY, RJ
PEDIATRICS, 1979, 63 (06) : 935 - 937
[23] TASK-FORCE REPORT
不详
JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 1994, 205 (02) : 301 - 303
[24] ANALYSIS OF THE PROCOAGULANT ACTIVITIES OF FACTOR-IX CONCENTRATES
MACKIE, IJ
SEGHATCHIAN, MJ
THROMBOSIS RESEARCH, 1982, 28 (04) : 499 - 507
[25] CURRENT STATUS OF STANDARDIZATION OF FACTOR-IX CONCENTRATES
ARONSON, DL
THROMBOSIS ET DIATHESIS HAEMORRHAGICA, 1971, : 447 - &
[26] Clinical use of factor VIII and factor IX concentrates
Morfini, Massimo
Coppola, Antonio
Franchini, Massimo
Di Minno, Giovanni
BLOOD TRANSFUSION, 2013, 11 : S55 - S63
[27] INVITRO THROMBOGENICITY TEST FOR CLINICAL FACTOR-IX CONCENTRATES USING SYNTHETIC SUBSTRATES
MILLERANDERSSON, M
SEGHATCHIAN, MJ
THROMBOSIS AND HAEMOSTASIS, 1977, 38 (01) : 162 - 162
[28] THE THROMBOGENICITY OF PROTHROMBIN COMPLEX CONCENTRATES AND FACTOR-IX CONCENTRATES IN-VIVO
HAMPTON, KK
HAEMOPHILIA, 1995, 1 : 26 - 27
[29] PREDICTION AND MANAGEMENT OF ADVERSE EVENTS ASSOCIATED WITH THE USE OF FACTOR-IX COMPLEX CONCENTRATES
LUSHER, JM
SEMINARS IN HEMATOLOGY, 1993, 30 (02) : 36 - 40
[30] CLINICAL-TRIAL OF MONOCLONAL FACTOR-IX AND COMPARISON TO PROTHROMBIN COMPLEX CONCENTRATES
KIM, HC
MATTS, L
EISELE, J
BERGMAN, G
SAIDI, P
TRANSFUSION, 1991, 31 (04) : 376 - 376

← 1 2 3 4 5 →